ImmunityBio, Inc. (IBRX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 44.21M | 38.28M | 32.06M | 26.43M | 16.52M | 7.55M | 6.11M | 1.05M | 40K | 139K | 82K | 41K |
| Revenue Growth % | 167.64% | 406.95% | 425.07% | 2423.88% | 41192.5% | 5333.09% | 7346.34% | 2453.66% | -88.89% | 90.41% | -30.51% | 17.14% |
| Cost of Goods Sold | 238K | 4.25M | 4.13M | 136K | 58K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 0.54% | 11.09% | 12.88% | 0.51% | 0.35% | - | - | - | - | - | - | - |
| Gross Profit | 43.97M | 34.04M | 27.93M | 26.29M | 16.46M | 7.55M | 6.11M | 1.05M | 40K | 139K | 82K | 41K |
| Gross Margin % | 99.46% | 88.91% | 87.12% | 99.49% | 99.65% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | 167.14% | 350.72% | 357.47% | 2410.89% | 41047.5% | 5333.09% | 7346.34% | 2453.66% | 100.68% | 102.04% | 101.4% | 100.7% |
| Operating Expenses | 113.76M | 98.72M | 83.56M | 97.57M | 80.89M | 76.95M | 86.36M | 100.38M | 95.24M | 85.53M | 80.22M | 85.19M |
| OpEx % of Revenue | 257.34% | 257.86% | 260.64% | 369.25% | 489.73% | 1018.96% | 1414.33% | 9587.39% | 238090% | 61530.94% | 97826.83% | 207770.73% |
| Selling, General & Admin | 44.46M | 37.83M | 32.83M | 42.34M | 32.65M | 41.73M | 35.92M | 49.25M | 41.88M | 33.11M | 31.82M | 32.02M |
| SG&A % of Revenue | 100.58% | 98.82% | 102.4% | 160.22% | 197.7% | 552.58% | 588.21% | 4704.01% | 104712.5% | 23820.14% | 38800% | 78092.68% |
| Research & Development | 64.77M | 60.81M | 50.73M | 55.24M | 48.23M | 35.22M | 50.44M | 51.13M | 53.35M | 51.53M | 48.4M | 53.17M |
| R&D % of Revenue | 146.52% | 158.83% | 158.24% | 209.03% | 292.03% | 466.38% | 826.12% | 4883.38% | 133377.5% | 37073.38% | 59026.83% | 129678.05% |
| Other Operating Expenses | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 886K | 0 | 0 |
| Operating Income | -69.79M | -64.68M | -55.63M | -71.28M | -64.43M | -69.4M | -80.25M | -99.33M | -95.2M | -85.39M | -80.14M | -85.14M |
| Operating Margin % | -157.88% | -168.95% | -173.51% | -269.76% | -390.08% | -918.96% | -1314.33% | -9487.39% | -237990% | -61430.94% | -97726.83% | -207670.73% |
| Operating Income Growth % | -8.32% | 6.8% | 30.68% | 28.24% | 32.32% | 18.72% | -0.15% | -16.66% | 14.68% | -1.39% | 11.75% | -6.94% |
| EBITDA | -65.41M | -60.82M | -51.68M | -67.41M | -60.6M | -65.25M | -75.81M | -94.93M | -90.64M | -80.83M | -75.6M | -80.46M |
| EBITDA Margin % | -147.97% | -158.86% | -161.19% | -255.08% | -366.89% | -863.96% | -1241.63% | -9066.57% | -226602.5% | -58147.48% | -92193.9% | -196251.22% |
| EBITDA Growth % | -7.94% | 6.79% | 31.83% | 28.99% | 33.14% | 19.28% | -0.28% | -17.98% | 13.92% | -4.5% | 10.88% | -9.19% |
| D&A (Non-Cash Add-back) | 4.38M | 3.87M | 3.95M | 3.88M | 3.83M | 4.15M | 4.44M | 4.41M | 4.55M | 4.56M | 4.54M | 4.68M |
| EBIT | -69.79M | -34.9M | -39.73M | -63.42M | -101.03M | -44.27M | -45.51M | -95.56M | -102.19M | -201.33M | -60.62M | -105.98M |
| Net Interest Income | -26.14M | -23.93M | -25.49M | -28.07M | -28.34M | -14.14M | -39.61M | -38.19M | -35.06M | -30.28M | -34.41M | -31.64M |
| Interest Income | 2.32M | 3.26M | 2.1M | 818K | 520K | 769K | 638K | 833K | 2.42M | 1.84M | 610K | 592K |
| Interest Expense | 28.46M | 27.19M | 27.58M | 28.88M | 28.86M | 14.9M | 40.25M | 39.02M | 37.49M | 32.13M | 35.02M | 32.23M |
| Other Income/Expense | -563M | 2.59M | -11.68M | -21.02M | -65.47M | 10.22M | -5.5M | -35.25M | -38.93M | -148.06M | -15.51M | -53.07M |
| Pretax Income | -632.79M | -62.09M | -67.31M | -92.31M | -129.9M | -59.18M | -85.75M | -134.58M | -134.13M | -233.45M | -95.64M | -138.21M |
| Pretax Margin % | -1431.46% | -162.19% | -209.94% | -349.31% | -786.46% | -783.62% | -1404.39% | -12854.25% | -335325% | -167952.52% | -116636.59% | -337104.88% |
| Income Tax | -9K | -135K | -35K | 269K | -234K | 0 | 0 | 0 | 0 | -40K | 0 | 0 |
| Effective Tax Rate % | 0% | 0.22% | 0.05% | -0.29% | 0.18% | 0% | 0% | 0% | 0% | 0.02% | 0% | 0% |
| Net Income | -632.78M | -61.94M | -67.25M | -92.56M | -129.65M | -59.16M | -85.73M | -134.56M | -134.11M | -233.39M | -95.58M | -137.88M |
| Net Margin % | -1431.44% | -161.8% | -209.77% | -350.26% | -784.92% | -783.4% | -1404.01% | -12852.34% | -335272.5% | -167907.91% | -116563.41% | -336290.24% |
| Net Income Growth % | -388.08% | -4.7% | 21.55% | 31.22% | 3.33% | 74.65% | 10.31% | 2.4% | -15.27% | -115.67% | 13.84% | -45.77% |
| Net Income (Continuing) | -632.78M | -61.96M | -67.27M | -92.57M | -129.67M | -59.18M | -85.75M | -134.58M | -134.13M | -233.41M | -95.64M | -138.21M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 880K | 895K | 909K | 930K | 949K | 969K | 986K | 1.01M | 1.03M | 1.05M | 1.07M | -3.07M |
| EPS (Diluted) | -0.62 | -0.06 | -0.07 | -0.10 | -0.15 | -0.09 | -0.12 | -0.20 | -0.20 | -0.40 | -0.19 | -0.32 |
| EPS Growth % | -313.33% | 30.44% | 40.83% | 50% | 25% | 77.5% | 36.84% | 37.5% | 42.86% | -48.15% | 32.14% | -33.33% |
| EPS (Basic) | -0.62 | -0.06 | -0.07 | -0.10 | -0.15 | -0.08 | -0.12 | -0.20 | -0.20 | -0.40 | -0.19 | -0.32 |
| Diluted Shares Outstanding | 1.03B | 989.68M | 946.6M | 888.22M | 853.16M | 734.54M | 697.96M | 686.94M | 672.83M | 590.73M | 498.38M | 437.46M |
| Basic Shares Outstanding | 1.03B | 989.68M | 946.6M | 888.22M | 853.16M | 733.2M | 695.89M | 686.94M | 672.83M | 590.73M | 498.38M | 437.46M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |